Your browser doesn't support javascript.
loading
Endogenous Antibody Responses to SARS-CoV-2 in Patients With Mild or Moderate COVID-19 Who Received Bamlanivimab Alone or Bamlanivimab and Etesevimab Together.
Zhang, Lin; Poorbaugh, Josh; Dougan, Michael; Chen, Peter; Gottlieb, Robert L; Huhn, Gregory; Beasley, Stephanie; Daniels, Montanea; Ngoc Vy Trinh, Thi; Crisp, Melissa; Freitas, Joshua Joaquin; Vaillancourt, Peter; Patel, Dipak R; Nirula, Ajay; Kallewaard, Nicole L; Higgs, Richard E; Benschop, Robert J.
Afiliação
  • Zhang L; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Poorbaugh J; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Dougan M; Massachusetts General Hospital and Harvard Medical School, Boston, MA, United States.
  • Chen P; Department of Medicine, Women's Guild Lung Institute, Cedars-Sinai Medical Center, Los Angeles, CA, United States.
  • Gottlieb RL; Department of Internal Medicine, Center for Advanced Heart and Lung Disease, Baylor University Medical Center, Dallas, TX, United States.
  • Huhn G; Baylor Scott & White Research Institute, Dallas, TX, United States.
  • Beasley S; The Ruth M. Rothstein CORE Center, Cook County Health, Chicago, IL, United States.
  • Daniels M; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Ngoc Vy Trinh T; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Crisp M; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Freitas JJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Vaillancourt P; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Patel DR; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Nirula A; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Kallewaard NL; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Higgs RE; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
  • Benschop RJ; Lilly Research Laboratories, Eli Lilly and Company, Indianapolis, IN, United States.
Front Immunol ; 12: 790469, 2021.
Article em En | MEDLINE | ID: mdl-34956222
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / COVID-19 / Tratamento Farmacológico da COVID-19 / Anticorpos Monoclonais / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Anticorpos Neutralizantes / Anticorpos Monoclonais Humanizados / COVID-19 / Tratamento Farmacológico da COVID-19 / Anticorpos Monoclonais / Anticorpos Antivirais Tipo de estudo: Clinical_trials Limite: Adult / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article